5SHI

Crystal Structure of human phosphodiesterase 10 in complex with 2,3,5-trimethyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]imidazo[1,2-a]pyridine

Experimental procedure

Experimental method	SINGLE WAVELENGTH
Source type	SYNCHROTRON
Source details	SLS BEAMLINE X10SA
Synchrotron site	SLS
Beamline	X10SA
Temperature [K]	100
Detector technology	PIXEL
Collection date	2011-11-22
Detector	PSI PILATUS 6M
Wavelength(s)	1.000000
Spacegroup name	H 3
Unit cell lengths	135.673, 135.673, 235.865
Unit cell angles	90.00, 90.00, 120.00

Refinement procedure

Resolution	43.780 - 2.100
R-factor	0.1761
Rwork	0.174
R-free	0.22330
Structure solution method	MOLECULAR REPLACEMENT
Starting model (for MR)	inhouse model
RMSD bond length	0.010
RMSD bond angle	1.599
Data reduction software	XDS
Data scaling software	XSCALE
Phasing software	PHASER
Refinement software	REFMAC (5.8.0258)

Data quality characteristics

	Overall	Inner shell	Outer shell
Low resolution limit [Å]	43.780	43.780	2.150
High resolution limit [Å]	2.100	9.390	2.100
Rmerge	0.064	0.016	1.305
Rmeas	0.071	0.018	1.449
Total number of observations	492577
Number of reflections	94423	1053	6985
<I/σ(I)>	16.07	64.85	1.24
Completeness [%]	99.9	99.1	99.9
Redundancy	5.217	5.1	5.327
CC(1/2)	0.999	1.000	0.470

Crystallization Conditions

crystal ID	method	pH	temperature	details
1	VAPOR DIFFUSION, SITTING DROP	7.5	295	5-20 mg/mL protein in 25mM HEPES/NaOH pH7.5, 150mM NaCl, 50mM BME mixed 1:1 with reservoir 0.1M HEPES/NaOH pH7.5, 30% PEG550MME, 50mM MgCl2